News + Filings Transactions Holdings
|
Versant Venture Capital III, L.P.
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/15/2015 | OCULAR THERAPEUTIX, INC | OCUL | Sale | Common Stock | 318.1k | $22.00 | $7M | | 06/15/2015 |
06/15/2015 | OCULAR THERAPEUTIX, INC | OCUL | Sale | Common Stock | 1.9k | $22.00 | $41.3k | See Footnote | 06/15/2015 |
06/10/2015 | OCULAR THERAPEUTIX, INC | OCUL | Sale | Common Stock | 424.5k | $22.00 | $9.3M | | 06/10/2015 |
06/10/2015 | OCULAR THERAPEUTIX, INC | OCUL | Sale | Common Stock | 2.5k | $22.00 | $55.1k | See Footnote | 06/10/2015 |
09/10/2014 | Flexion Therapeutics Inc | FLXN | Exercise (in-the-money or at-the-money) | Stock Option (right to buy) | 2.2k | $17.61 | $39.6k | see footnote | 09/10/2014 |
07/30/2014 | OCULAR THERAPEUTIX, INC | OCUL | Conversion | Series D Preferred Stock | 20.8k | $0.00 | $0 | See Footnote | 07/30/2014 |
07/30/2014 | OCULAR THERAPEUTIX, INC | OCUL | Conversion | Series D Preferred Stock | 3.5M | $0.00 | $0 | | 07/30/2014 |
07/30/2014 | OCULAR THERAPEUTIX, INC | OCUL | Conversion | Series C Preferred Stock | 14.4k | $0.00 | $0 | See Footnote | 07/30/2014 |
07/30/2014 | OCULAR THERAPEUTIX, INC | OCUL | Conversion | Series C Preferred Stock | 2.4M | $0.00 | $0 | | 07/30/2014 |
07/30/2014 | OCULAR THERAPEUTIX, INC | OCUL | Conversion | Series B Preferred Stock | 9.6k | $0.00 | $0 | See Footnote | 07/30/2014 |
07/30/2014 | OCULAR THERAPEUTIX, INC | OCUL | Conversion | Series B Preferred Stock | 1.6M | $0.00 | $0 | | 07/30/2014 |
07/30/2014 | OCULAR THERAPEUTIX, INC | OCUL | Conversion | Series A Preferred Stock | 1.2k | $0.00 | $0 | See Footnote | 07/30/2014 |
07/30/2014 | OCULAR THERAPEUTIX, INC | OCUL | Conversion | Series A Preferred Stock | 198.8k | $0.00 | $0 | | 07/30/2014 |
07/30/2014 | OCULAR THERAPEUTIX, INC | OCUL | Conversion | Common Stock | 17.4k | $0.00 | $0 | See Footnote | 07/30/2014 |
07/30/2014 | OCULAR THERAPEUTIX, INC | OCUL | Conversion | Common Stock | 2.9M | $0.00 | $0 | | 07/30/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Conversion | Common Stock | 611.6k | $0.00 | $0 | | 07/29/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Conversion | Common Stock | 531.8k | $0.00 | $0 | | 07/29/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Conversion | Common Stock | 733.9k | $0.00 | $0 | | 07/29/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Conversion | Common Stock | 305.8k | $0.00 | $0 | | 07/29/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Sale | Common Stock | 208.3k | $12.00 | $2.5M | | 07/29/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Purchase | Common Stock | 233.3k | $12.00 | $2.8M | | 07/29/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Conversion | Series A Preferred Stock | 733.9k | $0.00 | $0 | | 07/29/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Conversion | Series B Preferred Stock | 531.8k | $0.00 | $0 | | 07/29/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Conversion | Series C Preferred Stock | 611.6k | $0.00 | $0 | | 07/29/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Exercise (in-the-money or at-the-money) | Series C Preferred Stock Warrant (right to buy) | 305.8k | $8.18 | $2.5M | | 07/29/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Exercise (in-the-money or at-the-money) | Series C Preferred Stock | 305.8k | $0.00 | $0 | | 07/29/2014 |
07/29/2014 | Immune Design Corp. | IMDZ | Conversion | Series C Preferred Stock | 305.8k | $0.00 | $0 | | 07/29/2014 |
02/18/2014 | Flexion Therapeutics Inc | FLXN | Conversion | Common Stock | 356.7k | $0.00 | $0 | By Versant Development Fund III, LLC | 02/18/2014 |
02/18/2014 | Flexion Therapeutics Inc | FLXN | Conversion | Common Stock | 12k | $0.00 | $0 | By Versant Side Fund III, L.P. | 02/18/2014 |
02/18/2014 | Flexion Therapeutics Inc | FLXN | Conversion | Common Stock | 2M | $0.00 | $0 | | 02/18/2014 |
02/18/2014 | Flexion Therapeutics Inc | FLXN | Conversion | Series B Preferred Stock | 18.5k | $0.00 | $0 | By Versant Side Fund III, L.P. | 02/18/2014 |
02/18/2014 | Flexion Therapeutics Inc | FLXN | Conversion | Series B Preferred Stock | 3.1M | $0.00 | $0 | | 02/18/2014 |
02/18/2014 | Flexion Therapeutics Inc | FLXN | Conversion | Series A Preferred Stock | 2.9M | $0.00 | $0 | By Versant Development Fund III, LLC | 02/18/2014 |
02/18/2014 | Flexion Therapeutics Inc | FLXN | Conversion | Series A Preferred Stock | 97.8k | $0.00 | $0 | By Versant Side Fund III, L.P. | 02/18/2014 |
02/18/2014 | Flexion Therapeutics Inc | FLXN | Conversion | Series A Preferred Stock | 16.6M | $0.00 | $0 | | 02/18/2014 |
|
|